Internal Medicine, Gastroenterology · Missoula, MT
NPI
1821275900
Since 2008
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1930 W Broadway St Ste A
Missoula, MT, 59808
Phone (406) 541-6844
Groups this clinician bills Medicare through
Medicare paid, 2024
$112K
1,099 services
Medicare patients, 2024
542
Average age 73
Drug cost, 2024
$190K
902 prescriptions
Company payments, 2025
$42.16
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Scott T Cooper was code 99214 (office e&m - established), 152 times for 121 patients. In total Scott T Cooper billed 1,099 services in 57 codes, and Medicare paid $112K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-10-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 152 | 121 | $85.97 | $13K |
| 45385 Colonoscopy - Lesion Removal | Facility | 130 | 130 | $198.17 | $26K |
| 43239 Upper GI Endoscopy | Facility | 122 | 120 | $52.86 | $6,449 |
| 45380 Lower GI Endoscopy - Other | Facility | 91 | 90 | $89.47 | $8,142 |
| 99204 Office E&M - New | Office | 54 | 54 | $93.26 | $5,036 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 44 | 44 | $176.96 | $7,786 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 43 | 43 | $176.65 | $7,596 |
| 99232 Hospital E&M - Subsequent | Facility | 29 | 20 | $60.90 | $1,766 |
| 43242 Upper GI Endoscopy | Facility | 23 | 23 | $185.15 | $4,258 |
| 99223 Hospital E&M - Initial | Facility | 20 | 20 | $126.69 | $2,534 |
| 45390 Lower GI Endoscopy - Other | Facility | 19 | 19 | $264.70 | $5,029 |
| 99231 Hospital E&M - Subsequent | Facility | 18 | 18 | $38.52 | $693 |
| 99222 Hospital E&M - Initial | Facility | 16 | 16 | $101.66 | $1,627 |
| 45378 Lower GI Endoscopy - Other | Facility | 16 | 16 | $138.53 | $2,216 |
| 43248 Upper GI Endoscopy | Facility | 14 | 14 | $96.02 | $1,344 |
By year: 2022 $154K for 2,106 services; 2023 $117K for 1,282 services; 2024 $112K for 1,099 services.
Medicare prescription drug claims, 2024
In 2024, the drug Scott T Cooper prescribed most often to Medicare patients was Peg 3350-Electrolyte (Sodium Chloride/Nahco3/Kcl/Peg), with 145 prescriptions and refills. In total Scott T Cooper wrote 902 Medicare prescriptions that cost $190K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 145 | 145 | 140 | $3,588 |
| Pantoprazole Sodium Generic | 135 | 263 | 59 | $1,805 |
| Omeprazole Generic | 93 | 166 | 38 | $1,071 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 84 | 84 | 83 | $5,151 |
| Linzess Linaclotide | 55 | 59 | Under 11 | $31K |
| Famotidine Generic | 49 | 103 | 16 | $542 |
| Gavilyte-N Sodium Chloride/Nahco3/Kcl/Peg | 41 | 41 | 41 | $838 |
| Dexlansoprazole Dr Dexlansoprazole | 25 | 33 | Under 11 | $4,251 |
| Zenpep Lipase/Protease/Amylase | 25 | 35 | Under 11 | $85K |
| Esomeprazole Magnesium Generic | 24 | 26 | Under 11 | $353 |
| Dicyclomine Hcl Generic | 22 | 28 | Under 11 | $586 |
| Trulance Plecanatide | 22 | 24 | Under 11 | $13K |
| Movantik Naloxegol Oxalate | 19 | 19 | Under 11 | $7,798 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 17 | 17 | 17 | $251 |
| Sutab Sod Sulf/Pot Chloride/Mag Sulf | 13 | 13 | 13 | $1,993 |
Brand drugs: - claims; generic drugs: 679 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Scott T Cooper $42.16 ($42.16 in general payments such as food, travel and fees) from 2 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $23.74.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.